Literature DB >> 19797892

Mucous membrane pemphigoid with antibodies to the beta(3) subunit of Laminin 332 in a patient with acute myeloblastic leukemia and graft-versus-host disease.

Masakazu Takahara, Gaku Tsuji, Norito Ishii, Teruki Dainichi, Takashi Hashimoto, Kentaro Kohno, Kenjiro Kamezaki, Koji Nagafuji, Satoshi Takeuchi, Yoichi Moroi, Masutaka Furue.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797892     DOI: 10.1159/000243807

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  4 in total

1.  Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.

Authors:  Coralie Zumelzu; Marina Alexandre; Christelle Le Roux; Patricia Weber; Alexis Guyot; Annie Levy; Françoise Aucouturier; Sabine Mignot-Grootenboer; Frédéric Caux; Eve Maubec; Catherine Prost-Squarcioni
Journal:  Front Med (Lausanne)       Date:  2018-09-27

2.  Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases.

Authors:  F Giurdanella; A M Nijenhuis; G F H Diercks; M F Jonkman; H H Pas
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

3.  The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.

Authors:  Hua Qian; Yohei Natsuaki; Hiroshi Koga; Tamihiro Kawakami; Chiharu Tateishi; Daisuke Tsuruta; Norito Ishii; Xiaoguang Li; Takashi Hashimoto
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

Review 4.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.